Condition
Prostate Cancer Stage I
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Unknown2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06929065Not ApplicableCompleted
Randomized Trial of HIFU vs. Cryo for Prostate Cancer
NCT04627896Phase 2CompletedPrimary
Targeted Microwave Focal Therapy
NCT05631080Phase 4UnknownPrimary
Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer
NCT03789253RecruitingPrimary
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03522155Not ApplicableUnknownPrimary
Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies
Showing all 5 trials